mouse nerve growth factor

also known as Jinlujie · mNGF · S20060051

Developed for: cerebrovascular disorder · ischemic stroke
Investigated by: Dongguan People's Hospital · First Affiliated Hospital of Jinan University · First Affiliated Hospital of Shantou University Medical College · First Affiliated Hospital, Sun Yat-Sen University · Guangdong 999 Brain Hospital · Houjie Hospital of Dongguan City
+5 more
· Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · The First Affiliated Hospital of Guangdong Pharmaceutical University · The Third Affiliated hospital of Zhejiang Chinese Medical University · Wuhan University · Zhujiang Hospital

today NCT06737549 · Ph 4 NCT04041349 · Ph 4

202020212022202320242025202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT06737549	Dec 2024 → Dec 2027 expected	ischemic stroke	The Third Affiliated hospital of Zhejiang Chinese Medical University	Recruiting	No outcome recorded
Phase 4	NCT04041349	Sep 2019 → Nov 2020	cerebrovascular disorder	Zhujiang Hospital	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	mouse nerve growth factor	“The 20ug mouse nerve growth factor (NO. S20060051, Jinlujie) will be obtained from Hiteck Biopharmaceutical Co., Ltd., Wuhan, China.” NCT06737549 ↗ 1 NCT04041349 ↗
Known as	Jinlujie	“The 20ug mouse nerve growth factor (NO. S20060051, Jinlujie) will be obtained from Hiteck Biopharmaceutical Co., Ltd., Wuhan, China.” NCT06737549 ↗
Known as	mNGF	“Mouse Nerve Growth Factor (mNGF) is a soluble protein” NCT04041349 ↗
Known as	S20060051	“The 20ug mouse nerve growth factor (NO. S20060051, Jinlujie) will be obtained from Hiteck Biopharmaceutical Co., Ltd., Wuhan, China.” NCT06737549 ↗
Modality	Protein / enzyme biologic	“Mouse Nerve Growth Factor (mNGF) is a soluble protein” NCT04041349 ↗
Route	Intramuscular	“by intramuscular injection” NCT04041349 ↗